Clinical Research Directory
Browse clinical research sites, groups, and studies.
Amyloid PET in Patients With Mild Cognitive Impairment and Early Dementia
Sponsor: University Hospital, Ghent
Summary
The National Institute on Aging together with the Alzheimer's Association (NIA-AA) recently proposed the ATN classification which is based upon the pathological processes present in Alzheimer's disease (amyloid, tau and neurodegeneration). The amyloid and tau status can be defined using cerebrospinal fluid analysis but also non-invasively using an amyloid or tau PET scan. The N status can be defined using an \[18F\]-FDG PET scan which is in Belgium part of standard of care. Recently, it has been demonstrated, using different amyloid PET tracers, that early-frame amyloid scans can be a surrogate for \[18F\]-FDG PET scan.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
50
Start Date
2024-05-08
Completion Date
2026-05
Last Updated
2024-05-20
Healthy Volunteers
Not specified
Conditions
Interventions
PET scan
\[18F\]Vizamyl
Locations (1)
Van Weehaeghe D
Ghent, Belgium